{"id":30707,"date":"2023-07-03T07:11:39","date_gmt":"2023-07-03T11:11:39","guid":{"rendered":"https:\/\/ifintechworld.com\/investing\/novartiss-sandoz-launches-arthritis-treatment-in-us\/"},"modified":"2023-07-03T07:11:40","modified_gmt":"2023-07-03T11:11:40","slug":"novartiss-sandoz-launches-arthritis-treatment-in-us","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=30707","title":{"rendered":"Novartis’s Sandoz Launches Arthritis Treatment in US"},"content":{"rendered":"
\n
By Mauro Orru<\/pre>\n
Novartis’s generics-and-biosimilars division Sandoz made a high-concentration formulation of its Hyrimoz injection available in the U.S., effectively entering the country’s immunology market.<\/p>\n
The company made the announcement on Saturday, saying the Hyrimoz formulation is cleared to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and Crohn’s disease.<\/p>\n
\n
“This is an important moment for Sandoz and for the millions of patients living with chronic inflammatory diseases in the U.S.,” said Keren Haruvi, president of North America at Sandoz.<\/p>\n
Last year, Novartis said it was planning to spin off Sandoz and list it as a stand-alone company in Switzerland, a move that would focus the once-sprawling healthcare conglomerate solely on prescription drugs. The proposed spinoff is expected to take place in the second half of the year.<\/p>\n
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94<\/p>\n
<\/pre>\n<\/p><\/div>\n<\/div>\n
Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"
By Mauro Orru Novartis’s generics-and-biosimilars division Sandoz made a high-concentration formulation of its Hyrimoz injection available in the U.S., effectively entering the country’s immunology market. The company made the announcement on Saturday, saying the Hyrimoz formulation is cleared to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa […]<\/p>\n","protected":false},"author":1,"featured_media":1898,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[239],"tags":[83],"class_list":["post-30707","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-investing","tag-featured","post_format-post-format-video"],"yoast_head":"\nNovartis's Sandoz Launches Arthritis Treatment in US | iFintechWorld<\/title>\n<meta name=\"description\" content=\"By Mauro Orru Novartis's generics-and-biosimilars division Sandoz made a high-concentration formulation of its Hyrimoz injection available in the U.S.,\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=30707\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novartis's Sandoz Launches Arthritis Treatment in US | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"By Mauro Orru Novartis's generics-and-biosimilars division Sandoz made a high-concentration formulation of its Hyrimoz injection available in the U.S.,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=30707\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-03T11:11:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-03T11:11:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/mw_logo_social.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=30707#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=30707\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Novartis’s Sandoz Launches Arthritis Treatment in US\",\"datePublished\":\"2023-07-03T11:11:39+00:00\",\"dateModified\":\"2023-07-03T11:11:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=30707\"},\"wordCount\":161,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=30707#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=30707\",\"url\":\"https:\/\/ifintechworld.com\/?p=30707\",\"name\":\"Novartis's Sandoz Launches Arthritis Treatment in US | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-07-03T11:11:39+00:00\",\"dateModified\":\"2023-07-03T11:11:40+00:00\",\"description\":\"By Mauro Orru Novartis's generics-and-biosimilars division Sandoz made a high-concentration formulation of its Hyrimoz injection available in the U.S.,\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=30707#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=30707\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=30707#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novartis’s Sandoz Launches Arthritis Treatment in US\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novartis's Sandoz Launches Arthritis Treatment in US | iFintechWorld","description":"By Mauro Orru Novartis's generics-and-biosimilars division Sandoz made a high-concentration formulation of its Hyrimoz injection available in the U.S.,","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=30707","og_locale":"en_US","og_type":"article","og_title":"Novartis's Sandoz Launches Arthritis Treatment in US | iFintechWorld","og_description":"By Mauro Orru Novartis's generics-and-biosimilars division Sandoz made a high-concentration formulation of its Hyrimoz injection available in the U.S.,","og_url":"https:\/\/ifintechworld.com\/?p=30707","og_site_name":"iFintechWorld","article_published_time":"2023-07-03T11:11:39+00:00","article_modified_time":"2023-07-03T11:11:40+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/mw_logo_social.png","type":"image\/png"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=30707#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=30707"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Novartis’s Sandoz Launches Arthritis Treatment in US","datePublished":"2023-07-03T11:11:39+00:00","dateModified":"2023-07-03T11:11:40+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=30707"},"wordCount":161,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=30707#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=30707","url":"https:\/\/ifintechworld.com\/?p=30707","name":"Novartis's Sandoz Launches Arthritis Treatment in US | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-07-03T11:11:39+00:00","dateModified":"2023-07-03T11:11:40+00:00","description":"By Mauro Orru Novartis's generics-and-biosimilars division Sandoz made a high-concentration formulation of its Hyrimoz injection available in the U.S.,","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=30707#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=30707"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=30707#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Novartis’s Sandoz Launches Arthritis Treatment in US"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/30707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30707"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/30707\/revisions"}],"predecessor-version":[{"id":30708,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/30707\/revisions\/30708"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/1898"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}